NYSEAMERICAN : NRXS

NeurAxis, Inc. — Company profile

Healthcare · Biotechnology · United States

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Details

NameNeurAxis, Inc.
SectorHealthcare
IndustryBiotechnology
Employees24
Founded2011
Ipo Date2023-08-09
CeoBrian Carrico
CountryUnited States
ExchangeNYSEAMERICAN
Fiscal YearJanuary - December
Reporting CurrencyUSD
Ipo Price6.00
IsinUS64134X2018
Cusip64134X201
Cik1933567
Sic3845
Stock TypeCommon Stock

Key executives

NameTitle
Brian CarricoPresident, Chief Executive Officer and Director
Timothy Robert HenrichsChief Financial Officer
Dr. Adrian MirandaSenior Vice President of Science and Technology and Chief Medical Officer
Dr. Thomas CarricoChief Regulatory Officer and Compliance and Privacy Officer
Dr. Christopher Robin Brown D.D.S.Founder, Director of Innovation and Director
Ryan KuhlmanVice President of Sales
Trisha BaumgardtVice President of Marketing
Craig BlanchardChief Commercial Officer
Behnam Shamsian CPAInvestor Relations

Contact

Address11611 North Meridian St, Suite 330, Carmel, Indiana 46032, United States
Phone812 689 0791
Websitehttps://neuraxis.com